MedTrace Logo

3D-QFR in Non-selected Angiographic Stenosis. A Spanish Multicentre Study.

NCT05251012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 803

Last updated 2022-02-22

No results posted yet for this study

Summary

Physiology-based decision-making about the need for revascularisation in patients with stable coronary heart disease has consistently proven better clinical outcomes than a merely anatomical approach. However, against the current recommendations, revascularisation in most of patients with chronic coronary syndromes still relies on coronary angiography alone. The increase in costs and in procedural complexity of wire-based physiology may explain the latter. Therefore, a novel non-invasive functional quantitative flow ratio (QFR) index was created in order to solve it.

A retrospective and multicentre study is performed to assess the 5-year prognosis of patients undergoing coronary angiography through a centralized QFR analysis. Consecutive participants with confirmed or suspected diagnosis of stable coronary disease who underwent a coronary angiography between 01/01/2015 and 12/31/2015 were included.

Aims of the study:

* To evaluate the prognosis of stable coronary disease depending on the functional assessment of coronary artery disease.
* To determine the % of percutaneous coronary interventions that could be avoided if this study had been carried out through functional assessment of coronary artery disease based on 3-dimensional vessel reconstruction.

Conditions

Sponsors & Collaborators

  • Hospital Clínico Universitario Lozano Blesa

    collaborator OTHER

  • Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

    collaborator OTHER

  • Hospital General de Ciudad Real

    collaborator OTHER

  • Hospital de Leon

    collaborator OTHER_GOV

  • Hospital Universitario Virgen de la Arrixaca

    collaborator OTHER

  • Pablo Manuel Fernandez Corredoira

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251012 on ClinicalTrials.gov